ALPHA IVF GROUP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.31 MYR | -3.13% |
|
0.00% | 0.00% |
Valuation
| Fiscal Period: Mayo | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 1,507 | - | - |
| Enterprise Value (EV) 1 | 1,322 | 1,332 | 1,293 |
| P/E ratio | 29.1 x | 23.7 x | 21.3 x |
| Yield | 2.08% | 2.5% | 2.92% |
| Capitalization / Revenue | 9.02 x | 7.29 x | 5.7 x |
| EV / Revenue | 7.92 x | 6.45 x | 4.89 x |
| EV / EBITDA | 18.6 x | 13.8 x | 10.6 x |
| EV / FCF | 32.1 x | 76.6 x | 28.1 x |
| FCF Yield | 3.12% | 1.31% | 3.56% |
| Price to Book | 8 x | 7.62 x | 6.4 x |
| Nbr of stocks (in thousands) | 48,60,000 | - | - |
| Reference price 2 | 0.3200 | 0.3200 | 0.3200 |
| Announcement Date | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Mayo | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 167 | 206.6 | 264.3 |
| EBITDA 1 | - | 71 | 96.25 | 122.5 |
| EBIT 1 | - | 66.4 | 88.95 | 101.8 |
| Operating Margin | - | 39.77% | 43.05% | 38.52% |
| Earnings before Tax (EBT) 1 | - | 66.9 | 89.85 | 102.8 |
| Net income 1 | 53.24 | 51.75 | 66.05 | 72.9 |
| Net margin | - | 30.99% | 31.96% | 27.59% |
| EPS 2 | 0.0146 | 0.0110 | 0.0135 | 0.0150 |
| Free Cash Flow 1 | - | 41.2 | 17.4 | 46 |
| FCF margin | - | 24.68% | 8.42% | 17.41% |
| FCF Conversion (EBITDA) | - | 58.03% | 18.08% | 37.55% |
| FCF Conversion (Net income) | - | 79.61% | 26.34% | 63.1% |
| Dividend per Share 2 | - | 0.006670 | 0.008000 | 0.009330 |
| Announcement Date | 29/02/24 | - | - | - |
1MYR in Million2MYR
Estimates
Balance Sheet Analysis
| Fiscal Period: May | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 185 | 174 | 214 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | 41.2 | 17.4 | 46 |
| ROE (net income / shareholders' equity) | - | 38% | 28.2% | 26.4% |
| ROA (Net income/ Total Assets) | - | 27% | 22% | 20.8% |
| Assets 1 | - | 191.7 | 300.2 | 351.3 |
| Book Value Per Share 2 | - | 0.0400 | 0.0400 | 0.0500 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 13.8 | 5.8 | 19.2 |
| Capex / Sales | - | 8.27% | 2.81% | 7.27% |
| Announcement Date | 29/02/24 | - | - | - |
1MYR in Million2MYR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.31
MYR
Average target price
0.4
MYR
Spread / Average Target
+29.03%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 330M | |
| +4.89% | 213B | |
| +9.03% | 188B | |
| +30.51% | 157B | |
| +32.76% | 113B | |
| +5.25% | 64.85B | |
| +21.74% | 55.17B | |
| +1.34% | 49.1B | |
| -4.89% | 38.83B | |
| +1.51% | 35.6B |
- Stock Market
- Equities
- ALPHA Stock
- Financials Alpha IVF Group
